Pulmonary Rehabilitation
Treatment for Emphysema
Typical Dosage: 2-3 sessions per week, 1-2 hours per session
Effectiveness
88%
Safety Score
95%
Clinical Trials
34
Participants
25K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
2-3 sessions per week, 1-2 hours per session
Time to Effect
6-12 weeks
Treatment Duration
6-12 weeks intensive, then maintenance
Evidence Quality
HIGHNumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$3,000
Side Effect Mgmt:$50
Total Annual:$3,050
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$20,000/QALY
QALYs Gained
0.4
Outcome-Based Costs
Cost per Responder
$3,935
Pulmonary Rehabilitation Outcomes
for Emphysema
Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+78%
Common Side Effects
Musculoskeletal discomfort/injury (minor)
+8%
Fatigue (during sessions)
+15%
Sources:
Active Clinical Trials
3 active trials recruiting for Pulmonary Rehabilitation in Emphysema
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
NCT06304207RECRUITINGNA
30 participants
INTERVENTIONAL
Charlestown, United States
Started: Sep 1, 2023
Endobronchial Silicone Valve for Patients With Emphysema
NCT07097896NOT YET RECRUITINGNA
147 participants
INTERVENTIONAL
Beijing, China
Started: Jul 1, 2025
Zephyr Valve Registry (ZEVR)
NCT04186546ACTIVE NOT RECRUITING
150 participants
OBSERVATIONAL
Birmingham, United States +10 more
Started: Nov 25, 2019
Completed Clinical Trials
13 completed trials for Pulmonary Rehabilitation in Emphysema
A Trial on the Effects of Bronchoscopic Lung Volume Reduction in Severe Emphysema.
NCT03474471COMPLETEDNA
96 participants
INTERVENTIONAL
Groningen, Netherlands +1 more
Started: Jul 31, 2018
Home Pulmonary Rehabilitation for COPD
NCT03480386COMPLETEDNA
375 participants
INTERVENTIONAL
Jacksonville, United States +2 more
Started: Jan 1, 2019
Effect Of Pulmonary Rehabilitation in Patients With Alpha-1 Antitrypsin Deficiency
NCT07242079COMPLETED
50 participants
OBSERVATIONAL
Parma, Italy
Started: Nov 15, 2024
The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success
NCT04347044COMPLETEDNA
80 participants
INTERVENTIONAL
Started: Jan 1, 2013
Comparison of the Effectiveness of Home and Hospital-based PR in Candidate Patients With BLVR
NCT03518177COMPLETEDNA
66 participants
INTERVENTIONAL
Istanbul, Turkey (Türkiye)
Started: May 15, 2018
Innovation in Pulmonary Rehabilitation
NCT00123422COMPLETEDNA
103 participants
INTERVENTIONAL
Hines, United States
Started: Oct 1, 2005
Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients
NCT02999685COMPLETEDNA
154 participants
INTERVENTIONAL
Rochester, United States
Started: Sep 1, 2016
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
NCT01796392COMPLETEDNA
190 participants
INTERVENTIONAL
Birmingham, United States +22 more
Started: Jul 1, 2013
Examining Vascular Outcomes in COPD Inpatients (AIM 1) Examining Early Rehabilitation on Discharged COPD Patients (AIM 2)
NCT01949727COMPLETED
111 participants
OBSERVATIONAL
Edmonton, Canada
Started: Oct 1, 2013
Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function
NCT01812447COMPLETEDNA
172 participants
INTERVENTIONAL
Fort Smith, United States +33 more
Started: Jun 1, 2013
Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease
NCT00034112COMPLETEDPHASE2
INTERVENTIONAL
Kirksville, United States
Started: Apr 1, 2001
Examining Pulmonary Rehabilitation on Discharged COPD Patients
NCT02426437COMPLETEDNA
87 participants
INTERVENTIONAL
Edmonton, Canada
Started: Feb 1, 2015
Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study
NCT01719263COMPLETEDNA
69 participants
INTERVENTIONAL
Chermside, Australia +16 more
Started: Jun 1, 2013
Showing 20 of 34 total trials